//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

Events

Welcome to our products section. Browse a list of current events and courses below. To narrow the list of events by topic, simply click on the relevant link in the left menu.
  • Antibody Engineering & Therapeutics China
    August 12-13, 2015
    Grand Hyatt Shanghai, Shanghai, CN
    IBC's Antibody Engineering & Therapeutics China meeting is the leading forum in Asia for bringing together leading scientists and innovators from around the world to discuss novel strategies for antibody, protein and biotherapeutic discovery and development.
  • BioProcess International China Conference & Exhibition
    August 12-13, 2015
    Grand Hyatt Shanghai, Shanghai, CN
    BioProcess International China conference is the region's foremost event on bioprocessing and biomanufacturing. It provides you with the most timely information, tools, strategies and techniques that you need to ensure optimal development, from upstream to scale-up to commercialization.
  • Cell Therapy Bioprocessing & Commercialization
    September 30 - October 02, 2015
    The Hilton Alexandria Mark Center, Alexandria, VA
    IBC's Cell Therapy Bioprocessing conference has built a reputation of providing a first-rate faculty of participants, who collectively share perspectives and lessons learned from detailed case studies to help you overcome the challenges, develop the strategies and implement the technologies to propel this field towards commercial sustainability.
  • Next Generation Cancer Immuno Therapies
    September 30 - October 01, 2015
    The Hilton Alexandria Mark Center, Alexandria, VA
    Providing insights on the latest advances in cancer immunotherapies, IBC's Immuno-Oncology meeting will focus on overcoming challenges with discovery, development, approval, and product launch. Discussions will cover methods to improve efficacy, potency, and viability of potential therapeutic candidates.
  • BioProcess International Conference & Exposition
    October 26-29, 2015
    John B Hynes Veterans Memorial Convention Center, Boston, MA
    BPI is engineered to be exactly what you need it to be... Only the largest bioprocessing event brings you new ideas, demystifies technology, and fosters partnerships in highly interactive formats to move drug candidates closer to approval.
  • Targeted Therapeutics: Discovery through Genomic Data
    November 05-06, 2015
    Hilton San Francisco Union Square, San Francisco, CA
    IBC's Targeted Therapeutics meeting is the premier conference to identify trends, paths and abnormalities to create more effective treatments through genomic and biomarker data analysis.
  • Drug Discovery: Biomarkers and Breakthroughs
    November 05-06, 2015
    Hilton San Francisco Union Square, San Francisco, CA
    With the incredible amount of growth and advancement in drug discovery with biomarkers and breakthrough therapeutics, it is more critical than ever to understand the latest methods and techniques for improving discovery efforts.
  • Well Characterized Biologicals
    November 09-10, 2015
    Hyatt Regency Reston, Reston, VA
    IBC's Well Characterized Biologicals meeting ensures CMC Success through novel characterization strategies and regulatory guidance.
  • Immunogenicity for Biotherapeutics
    November 09-10, 2015
    Hyatt Regency Reston, Reston, VA
    The premier forum for hearing the latest tests, processes, and strategies that assesses and provides the most accurate safety information on the immune response prediction to accelerate the process from concept to regulatory approval.
  • Antibody Engineering & Therapeutics
    December 07-10, 2015
    San Diego Convention Center, San Diego, CA
    IBC's Antibody Engineering & Therapeutics conference is an invaluable resource for your research programs. Attending these meetings means getting important updates from the early stage work of leading academic researchers and tracking the progress of companies advancing antibody therapeutics through clinical development. Covering both cutting-edge developments in the basic science of antibody engineering and clinical/preclinical updates of therapeutic antibodies in development.